HomeCompareJMP vs MRK

JMP vs MRK: Dividend Comparison 2026

JMP yields 39.55% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $3.5K in total portfolio value· pulled ahead in Year 8
10 years
JMP
JMP
● Live price
39.55%
Share price
$7.50
Annual div
$2.97
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$27.3K
Annual income
$5.35
Full JMP calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — JMP vs MRK

📍 MRK pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodJMPMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, JMP + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
JMP pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JMP
Annual income on $10K today (after 15% tax)
$3,361.47/yr
After 10yr DRIP, annual income (after tax)
$4.55/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, MRK beats the other by $803.20/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JMP + MRK for your $10,000?

JMP: 50%MRK: 50%
100% MRK50/50100% JMP
Portfolio after 10yr
$29.0K
Annual income
$477.83/yr
Blended yield
1.65%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

JMP
Analyst Ratings
3
Buy
2
Hold
Consensus: Buy
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JMP buys
0
MRK buys
0
No recent congressional trades found for JMP or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricJMPMRK
Forward yield39.55%3.25%
Annual dividend / share$2.97$3.08
Payout ratio50%42%
1-year div growth0%5.5%
5-year div CAGR-50%8.2%
Portfolio after 10y$27.3K$30.7K
Annual income after 10y$5.35$950.29
Total dividends collected$4.5K$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: JMP vs MRK ($10,000, DRIP)

YearJMP PortfolioJMP Income/yrMRK PortfolioMRK Income/yrGap
1$12,677$1,977.33$11,192$351.54+$1.5KJMP
2$14,736$1,171.37$12,524$392.70+$2.2KJMP
3$16,404$636.26$14,015$438.65+$2.4KJMP
4$17,883$330.97$15,682$489.96+$2.2KJMP
5$19,304$168.60$17,547$547.23+$1.8KJMP
6$20,740$85.04$19,632$611.16+$1.1KJMP
7$22,234$42.70$21,963$682.53+$271.00JMP
8← crossover$23,812$21.39$24,571$762.18$759.00MRK
9$25,490$10.70$27,486$851.08$2.0KMRK
10$27,279$5.35$30,745$950.29$3.5KMRK

JMP vs MRK: Complete Analysis 2026

JMPStock

JMP Group LLC provides investment banking, sales and trading, and equity research services to corporate and institutional clients, and alternative asset management products and services to institutional investors and high net-worth individuals. The company is headquartered in San Francisco, California and currently employs 226 full-time employees. The firm operates in five segments: Broker-Dealer, Asset Management, Corporate Credit, Investment Income and Corporate Costs. The Broker-Dealer segment includes a range of services, such as underwriting and acting as a placement agent for public and private capital markets raising transactions and financial advisory services in mergers and acquisitions, restructuring and other strategic transactions. The Asset Management segment includes the management of a range of pooled investment vehicles. The Corporate Credit segment includes the management of collateralized loan obligations and small business loans. The Investment Income segment includes income from the Company's principal investments in public and private securities.

Full JMP Calculator →

MRKHealthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this JMP vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JMP vs SCHDJMP vs JEPIJMP vs OJMP vs KOJMP vs MAINJMP vs JNJJMP vs ABBVJMP vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.